EP4218754
VANZACAFTOR FOR USE IN THE TREATMENT OF CYSTIC FIBROSIS
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
13.11.2019EP published:
25.3.2026EP application number:
23154663.1
EPO information:
European Patent Register
Max expiry date:
12.11.2039Expiry date:
12.11.2026
Title in English:
VANZACAFTOR FOR USE IN THE TREATMENT OF CYSTIC FIBROSISLanguage of the patent:
English
Timeline
Today
13.11.2019EP application
25.3.2026EP Publication
12.11.2026Expires
Owner
Name:
Vertex Pharmaceuticals IncorporatedAddress:
50 Northern Avenue, Boston, MA 02210, US
Inventor
Name:
ALTSHULER, David M.Address:
Boston, 02210, US
Name:
ANDERSON, Corey DonAddress:
Boston, 02210, US
Name:
CHEN, Weichao GeorgeAddress:
Boston, 02210, US
Name:
CLEMENS, Jeremy JAddress:
Boston, 02210, US
Name:
CLEVELAND, ThomasAddress:
Boston, 02210, US
Name:
COON, Timothy RichardAddress:
Boston, 02210, US
Name:
FRIEMAN, BryanAddress:
Boston, 02210, US
Name:
GROOTENHUIS, PeterAddress:
deceased, US
Name:
HADIDA RUAH, Sara SabinaAddress:
Boston, 02210, US
Name:
HARE, Brian J.Address:
Boston, 02210, US
Name:
KEWALRAMANI, ReshmaAddress:
Boston, 02210, US
Name:
MCCARTNEY, JasonAddress:
Boston, 02210, US
Name:
MILLER, Mark ThomasAddress:
Boston, 02210, US
Name:
PARASELLI, PrasunaAddress:
Boston, 02210, US
Name:
PIERRE, FabriceAddress:
Boston, 02210, US
Name:
ROBERTSON, Sarah M.Address:
Boston, 02210, US
Name:
SOSNAY, Patrick R.Address:
Boston, 02210, US
Name:
SWIFT, Sara E.Address:
Boston, 02210, US
Name:
ZHOU, JinglanAddress:
Boston, 02210, US
Name:
BOREK, BartlomiejAddress:
Boston, 02210, US
Name:
VAN GOOR, FredrickAddress:
Boston, 02210, US
Name:
YOUNG, TimAddress:
Boston, 02210, US
Priority
Number:
201862767202 PDate:
14.11.2018Country:
US
Classification
Categories:
A61K 31/404, A61K 45/06, A61K 31/47, A61P 11/00